Mirae Asset Global Etfs Holdings Ltd. Kymera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,611 shares of KYMR stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,611
Previous 30,793
10.33%
Holding current value
$1.6 Million
Previous $842,000
42.99%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding KYMR
# of Institutions
217Shares Held
72.2MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$397 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$385 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$380 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$325 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$319 Million9.44% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.17B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...